Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting

NEXT STORY
Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates 
PREV STORY
Hemispherx Reports Positive Safety and Survival Data in Phase 1 Stage 4 Ovarian Cancer Clinical Study Using Ampligen®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Psoria-Shield, Inc. Expands Relationship with Prominent Healthcare Organization

HOFFMAN ESTATES, IL, June 19, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI), ...

author_avatar
NASDAQ Market News

NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSV∆G-ZEBOV-GP) to U.S. Food and Drug Administration

In 2014 the Company entered into a license agreement with Merck to develop, manufacture ...

author_avatar
NASDAQ Market News

Radius Health Announces Plans for Global Prader-Willi Syndrome Pivotal Study

author_avatar
NASDAQ Market News